Circulating carcinoembryonic antigen in pancreatic carcinoma

M. H. Kalser, Jamie S Barkin, D. Redlhammer, A. Heal

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Circulating CEA levels were determined in 102 patients with histologically proven pancreatic carcinoma and 26 patients with chronic pancreatitis. In the group with pancreatic carcinoma eleven patients had resectable tumors, the mean CEA in the nonjaundiced patients was 10±5 ng/ml while the mean value in jaundiced patients in this group was 27±40. Thirty-four patients with nonmetastatic locally unresectable disease had a mean serum CEA of 25±52 with a range of 1 to 250 ng/ml. Twenty-one percent had values of 5 ng/ml or less. The mean value in 57 patients with metastatic disease was 97±194 with a range of 0.5 to 1000 ng/ml and 19 percent had values of 5 ng/ml or less. Survival of patients with locally unresectable or metastatic carcinoma was significantly longer in those patients who had a normal CEA at the time of diagnosis. Circulating CEA in the metastatic group was much lower in patients with nonhepatic metastases as well as in those with well differentiated adenocarcinoma histology. Twenty-three patients with chronic pancreatitis and normal serum bilirubin had a mean CEA value of 5.3±4 ng/ml with 65% of values being 5 ng/ml or less but the CEA ranged from 4.6 to 27 in three who were jaundiced.

Original languageEnglish
Pages (from-to)1468-1471
Number of pages4
JournalCancer
Volume42
Issue number3 . SUPPL.
StatePublished - Dec 1 1978

Fingerprint

Carcinoembryonic Antigen
Chronic Pancreatitis
Jaundice
Pancreatic Carcinoma
Serum
Bilirubin
Histology
Adenocarcinoma
Neoplasm Metastasis
Carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kalser, M. H., Barkin, J. S., Redlhammer, D., & Heal, A. (1978). Circulating carcinoembryonic antigen in pancreatic carcinoma. Cancer, 42(3 . SUPPL.), 1468-1471.

Circulating carcinoembryonic antigen in pancreatic carcinoma. / Kalser, M. H.; Barkin, Jamie S; Redlhammer, D.; Heal, A.

In: Cancer, Vol. 42, No. 3 . SUPPL., 01.12.1978, p. 1468-1471.

Research output: Contribution to journalArticle

Kalser, MH, Barkin, JS, Redlhammer, D & Heal, A 1978, 'Circulating carcinoembryonic antigen in pancreatic carcinoma', Cancer, vol. 42, no. 3 . SUPPL., pp. 1468-1471.
Kalser MH, Barkin JS, Redlhammer D, Heal A. Circulating carcinoembryonic antigen in pancreatic carcinoma. Cancer. 1978 Dec 1;42(3 . SUPPL.):1468-1471.
Kalser, M. H. ; Barkin, Jamie S ; Redlhammer, D. ; Heal, A. / Circulating carcinoembryonic antigen in pancreatic carcinoma. In: Cancer. 1978 ; Vol. 42, No. 3 . SUPPL. pp. 1468-1471.
@article{10d7ebf0d9c94f3c80fbab12a008e613,
title = "Circulating carcinoembryonic antigen in pancreatic carcinoma",
abstract = "Circulating CEA levels were determined in 102 patients with histologically proven pancreatic carcinoma and 26 patients with chronic pancreatitis. In the group with pancreatic carcinoma eleven patients had resectable tumors, the mean CEA in the nonjaundiced patients was 10±5 ng/ml while the mean value in jaundiced patients in this group was 27±40. Thirty-four patients with nonmetastatic locally unresectable disease had a mean serum CEA of 25±52 with a range of 1 to 250 ng/ml. Twenty-one percent had values of 5 ng/ml or less. The mean value in 57 patients with metastatic disease was 97±194 with a range of 0.5 to 1000 ng/ml and 19 percent had values of 5 ng/ml or less. Survival of patients with locally unresectable or metastatic carcinoma was significantly longer in those patients who had a normal CEA at the time of diagnosis. Circulating CEA in the metastatic group was much lower in patients with nonhepatic metastases as well as in those with well differentiated adenocarcinoma histology. Twenty-three patients with chronic pancreatitis and normal serum bilirubin had a mean CEA value of 5.3±4 ng/ml with 65{\%} of values being 5 ng/ml or less but the CEA ranged from 4.6 to 27 in three who were jaundiced.",
author = "Kalser, {M. H.} and Barkin, {Jamie S} and D. Redlhammer and A. Heal",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "42",
pages = "1468--1471",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3 . SUPPL.",

}

TY - JOUR

T1 - Circulating carcinoembryonic antigen in pancreatic carcinoma

AU - Kalser, M. H.

AU - Barkin, Jamie S

AU - Redlhammer, D.

AU - Heal, A.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - Circulating CEA levels were determined in 102 patients with histologically proven pancreatic carcinoma and 26 patients with chronic pancreatitis. In the group with pancreatic carcinoma eleven patients had resectable tumors, the mean CEA in the nonjaundiced patients was 10±5 ng/ml while the mean value in jaundiced patients in this group was 27±40. Thirty-four patients with nonmetastatic locally unresectable disease had a mean serum CEA of 25±52 with a range of 1 to 250 ng/ml. Twenty-one percent had values of 5 ng/ml or less. The mean value in 57 patients with metastatic disease was 97±194 with a range of 0.5 to 1000 ng/ml and 19 percent had values of 5 ng/ml or less. Survival of patients with locally unresectable or metastatic carcinoma was significantly longer in those patients who had a normal CEA at the time of diagnosis. Circulating CEA in the metastatic group was much lower in patients with nonhepatic metastases as well as in those with well differentiated adenocarcinoma histology. Twenty-three patients with chronic pancreatitis and normal serum bilirubin had a mean CEA value of 5.3±4 ng/ml with 65% of values being 5 ng/ml or less but the CEA ranged from 4.6 to 27 in three who were jaundiced.

AB - Circulating CEA levels were determined in 102 patients with histologically proven pancreatic carcinoma and 26 patients with chronic pancreatitis. In the group with pancreatic carcinoma eleven patients had resectable tumors, the mean CEA in the nonjaundiced patients was 10±5 ng/ml while the mean value in jaundiced patients in this group was 27±40. Thirty-four patients with nonmetastatic locally unresectable disease had a mean serum CEA of 25±52 with a range of 1 to 250 ng/ml. Twenty-one percent had values of 5 ng/ml or less. The mean value in 57 patients with metastatic disease was 97±194 with a range of 0.5 to 1000 ng/ml and 19 percent had values of 5 ng/ml or less. Survival of patients with locally unresectable or metastatic carcinoma was significantly longer in those patients who had a normal CEA at the time of diagnosis. Circulating CEA in the metastatic group was much lower in patients with nonhepatic metastases as well as in those with well differentiated adenocarcinoma histology. Twenty-three patients with chronic pancreatitis and normal serum bilirubin had a mean CEA value of 5.3±4 ng/ml with 65% of values being 5 ng/ml or less but the CEA ranged from 4.6 to 27 in three who were jaundiced.

UR - http://www.scopus.com/inward/record.url?scp=0018150310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018150310&partnerID=8YFLogxK

M3 - Article

C2 - 709516

AN - SCOPUS:0018150310

VL - 42

SP - 1468

EP - 1471

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3 . SUPPL.

ER -